HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Asaka Selected Research

Peptides (Polypeptides)

1/2016Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
7/2012Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease.
2/2011The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiro Asaka Research Topics

Disease

46Neoplasms (Cancer)
12/2021 - 08/2002
29Infections
06/2022 - 01/2002
22Stomach Neoplasms (Stomach Cancer)
10/2020 - 09/2003
15Colorectal Neoplasms (Colorectal Cancer)
04/2014 - 12/2004
10Ulcer
06/2022 - 01/2003
10Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2010 - 07/2003
10Graft vs Host Disease (Graft-Versus-Host Disease)
06/2009 - 03/2004
9Anorexia
09/2017 - 06/2008
9Colitis
01/2012 - 07/2002
8Peptic Ulcer (Peptic Ulcers)
06/2022 - 01/2003
8Inflammation (Inflammations)
10/2020 - 02/2005
8Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 02/2003
8Hypoxia (Hypoxemia)
01/2016 - 02/2003
8Carcinogenesis
02/2014 - 11/2003
8Gastroesophageal Reflux (GERD)
07/2012 - 04/2006
8Carcinoma (Carcinomatosis)
05/2012 - 01/2002
8Leukemia
03/2010 - 02/2003
7Lymphoma (Lymphomas)
05/2012 - 06/2004
7Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
07/2011 - 11/2003
7Neutropenia
07/2010 - 05/2004
6Neoplasm Metastasis (Metastasis)
01/2016 - 06/2004
6Hepatocellular Carcinoma (Hepatoma)
02/2014 - 03/2003
5Colonic Neoplasms (Colon Cancer)
12/2021 - 04/2008
5Wounds and Injuries (Trauma)
09/2017 - 10/2007
5Rheumatoid Arthritis
05/2012 - 01/2005
5Disease Progression
03/2011 - 09/2004
5Hematologic Neoplasms (Hematological Malignancy)
04/2010 - 02/2003
5Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2010 - 04/2005
4Pathologic Constriction (Stenosis)
09/2017 - 07/2011
4Dyspepsia (Indigestion)
09/2017 - 10/2010
4Multiple Myeloma
11/2008 - 12/2004
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008 - 05/2004
3Gastritis
10/2017 - 01/2002
3Vomiting
09/2017 - 06/2008
3Nausea
09/2017 - 06/2006
3Duodenal Ulcer (Curling's Ulcer)
01/2016 - 02/2010
3Thrombosis (Thrombus)
07/2011 - 10/2008
3Hemorrhage
04/2011 - 10/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2011 - 07/2003
3Stomach Ulcer (Gastric Ulcer)
11/2010 - 01/2006
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2010 - 04/2004
3Aplastic Anemia (Anemia, Hypoplastic)
05/2009 - 07/2002
3Laryngopharyngeal Reflux
08/2008 - 04/2006
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2008 - 09/2004
3Pathologic Complete Response
05/2008 - 07/2003
3Adenocarcinoma
02/2007 - 01/2002

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
05/2012 - 05/2005
11Proteins (Proteins, Gene)FDA Link
03/2017 - 11/2003
8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2022 - 01/2005
8Rituximab (Mabthera)FDA Link
05/2012 - 03/2004
8Irinotecan (Camptosar)FDA LinkGeneric
08/2011 - 02/2005
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2011 - 10/2007
7liu-jun-zi-tangIBA
09/2017 - 06/2008
7Cisplatin (Platino)FDA LinkGeneric
09/2017 - 04/2007
7Macrophage Migration-Inhibitory FactorsIBA
04/2011 - 07/2002
6DNA (Deoxyribonucleic Acid)IBA
04/2013 - 02/2004
6Dextran SulfateIBA
01/2012 - 07/2002
5GhrelinIBA
01/2013 - 01/2010
5InterferonsIBA
11/2012 - 12/2004
5Messenger RNA (mRNA)IBA
07/2012 - 07/2002
5Fluorouracil (Carac)FDA LinkGeneric
08/2011 - 06/2007
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2008 - 10/2004
4RNA (Ribonucleic Acid)IBA
12/2021 - 08/2003
4Lansoprazole (Prevacid)FDA LinkGeneric
01/2016 - 01/2003
4Clarithromycin (Biaxin)FDA LinkGeneric
01/2016 - 02/2002
4IodineIBA
01/2015 - 01/2006
4Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2014 - 09/2005
4Biological ProductsIBA
02/2014 - 08/2003
4Pepsinogen A (Pepsinogen)IBA
02/2013 - 12/2010
4CytokinesIBA
01/2011 - 07/2002
4Immunoglobulins (Immunoglobulin)IBA
10/2010 - 11/2005
4AcidsIBA
01/2009 - 04/2006
4SolutionsIBA
04/2008 - 09/2005
3Transcription Factors (Transcription Factor)IBA
01/2016 - 08/2003
3Peptides (Polypeptides)IBA
01/2016 - 02/2011
3Amoxicillin (Wymox)FDA LinkGeneric
01/2016 - 01/2003
3Serotonin (5 Hydroxytryptamine)IBA
01/2013 - 01/2011
3CarcinogensIBA
10/2012 - 01/2002
3Leucovorin (Folinic Acid)FDA Link
08/2011 - 06/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 09/2005
3Matrix Metalloproteinases (MMPs)IBA
11/2009 - 08/2005
3Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2009 - 09/2004
3Anti-Bacterial Agents (Antibiotics)IBA
05/2009 - 01/2007
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2008 - 07/2002
3Glucose (Dextrose)FDA LinkGeneric
09/2007 - 04/2003
3Therapeutic UsesIBA
07/2007 - 09/2005
3geranylgeranylacetone (teprenone)IBA
03/2006 - 09/2005
3Imatinib Mesylate (Gleevec)FDA Link
01/2006 - 10/2004

Therapy/Procedure

56Therapeutics
06/2022 - 02/2002
26Drug Therapy (Chemotherapy)
09/2017 - 07/2003
11Hematopoietic Stem Cell Transplantation
03/2011 - 02/2005
7Stem Cell Transplantation
03/2010 - 03/2004
6Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2008 - 07/2002
5Secondary Prevention
03/2013 - 10/2008
5Aftercare (After-Treatment)
07/2011 - 01/2003
5Transplantation
03/2011 - 09/2004
4Immunotherapy
01/2016 - 01/2005
4Kampo Medicine (Kampo)
07/2012 - 10/2010
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2008 - 07/2003
3Oral Administration
09/2017 - 09/2005